Press Releases

BOSTON, MA – February 25, 2021 – Netcapital Inc. (OTC: NCPL), a fintech company dedicated to democratizing private capital markets and empowering entrepreneurs to succeed, announced a partnership with Rialto Markets, an innovative registered broker-dealer operating an alternative trading system (AT...

BOSTON, MA – January 12, 2021 – Netcapital Inc. (OTC: NCPL) announced it will partner with C-Reveal Therapeutics to advance the company’s patent pending approach to exposing tumors to immune responses and therapies. As an indication of its high conviction in the company, Netcapital Inc. has taken a...

BOSTON, MA – December 15, 2020 – Netcapital Inc. (OTC: NCPL), a fintech company dedicated to democratizing private capital markets and empowering entrepreneurs to succeed, announced first half 2021 revenues of $2,493,486, an increase of 198% over the previous year. The company reported a gross pro...

BOSTON, MA – December 8, 2020 – Netcapital Inc. (OTC: NCPL) a fintech company dedicated to democratizing private capital markets and empowering entrepreneurs to succeed, announced that a digital capital raise by MAGFAST® via Netcapital generated overwhelming investor interest, propelling the maker o...

BOSTON, MA – December 3, 2020 – Netcapital Inc. (OTC: NCPL), a fintech company dedicated to democratizing private capital markets and empowering entrepreneurs to succeed, announced that the company’s stock has been designated Penny Stock Exempt by OTC Markets, in accordance with the Securities and...

BOSTON, MA – November 17, 2020 – Netcapital, Inc. (OTC: VSTRD) announced that portfolio company ChipBrain’s Netcapital.com offering generated overwhelming investor interest, propelling the innovative AI start-up to reach the maximum capital threshold rapidly, resulting in an early close and paving t...

BOSTON, MA – November 10, 2020 – Netcapital Inc. (OTC: VSTRD) announced that portfolio company Vymedic’s clinically proven antiviral will be delivered to market this December, in time for flu season. Vymedic has partnered with a premier nutraceutical manufacturer to produce Vymune®, the company’s in...

BOSTON, MA – November 4, 2020 – ValueSetters, Inc. (OTC:VSTR) today announced that the company will change its name to Netcapital Inc. effective November 5, 2020. Additionally, pursuant to the previously announced merger of ValueSetters and Netcapital, ValueSetters’common stock will commence trading...

BOSTON, MA – October 15, 2020 – ValueSetters, Inc. (OTC:VSTR) announced that the company will partner with Vymedic to advance its innovative, patented approach to helping millions impacted by influenza, the common cold and other viruses. As an indication of its high conviction in the company, ValueS...

BOSTON, MA – September 21, 2020 – ValueSetters, Inc. (OTC:VSTR) announced first quarter 2021 revenues of $1,762,322 and operating income of $52,495. Revenues increased by 1,384% over the previous year, while operating income increased 80%. The company reported a gross profit margin of 76% and positi...